Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Unicycive Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Unicycive Therapeutics Inc. June 9, 202596.0%
-
Unicycive Therapeutics Inc. June 20, 202499.4%
-
Unicycive Therapeutics Inc. June 26, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 25, 2025 | Unicycive Therapeutics Inc. | Derivative conversion | +652,900 | — | — |
| Feb 18, 2025 | Unicycive Therapeutics Inc. | Derivative conversion | +1,400,000 | — | — |
| Oct 9, 2024 | Unicycive Therapeutics Inc. | Derivative conversion | +5,500,000 | — | — |
| Dec 29, 2023 | Geron Corporation | Grant or award | +1,970 | — | — |
| Jul 11, 2023 | Unicycive Therapeutics Inc. | Derivative conversion | +3,470,152 | — | — |
Questions about Gaurav Aggarwal
What boards is Gaurav Aggarwal on?
Gaurav Aggarwal sits on the boards of Geron Corporation and Unicycive Therapeutics Inc.
How long has Gaurav Aggarwal served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.